大和:維持明源雲(0909.HK)目標價40港元 料ERP業務持續復甦
大和發表研究報吿指,明源雲(0909.HK)管理層表示公司上半年企業資源管理(ERP)業務錄強勁反彈,預期下半年的銷售動力持續,客户需求有所改善,預期公司增加對進階ERP功能的推廣將會進一步提升平均每付費用户收入(ARPPU),料今年ERP業務收入按年升18%,維持目標價40港元,重申“優於大市”評級。
該行表示,相信公司能增加SaaS(軟件即服務)模組的交叉銷售,來帶動相關業務增長,上調公司2021年至2022年的收入增長預測0.4%至0.9%,但下調其每股盈利預測10.3%至11.7%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.